Cardiovascular Diseases Research
At Spaolo s.r.o. in Stara Tura, the clinical trial activity is centered on cardiovascular diseases, with a focus on conditions that drive major health risks in adults. The studies are designed to better understand and reduce serious outcomes linked to hypertension, atherosclerotic cardiovascular disease, and related high-risk heart and vessel conditions.
- Evaluating new treatments for hypertension that is not adequately controlled
- Studying prevention of major events in established cardiovascular disease and high cardiovascular risk
- Assessing approaches aimed at lowering the chance of heart attack, stroke, and heart failure events
These trials also involve participants with chronic kidney disease, reflecting the close connection between kidney health and cardiovascular outcomes. Overall, the research is focused on testing whether new therapies can improve event prevention and support better long-term cardiovascular care.
Heart and Kidney Risk Reduction Studies
The clinical research at this site includes studies that look beyond symptom control and aim to improve long-term outcomes in people with combined cardiovascular and kidney-related risk. The main diseases being studied include atherosclerosis, chronic kidney disease, and broader cardiovascular disease risk profiles.
- Testing whether a new therapy can reduce major cardiovascular events
- Exploring treatment options for adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
- Comparing investigational approaches against placebo to understand preventive benefit
In this setting, the goal is to determine whether emerging therapies can lower the risk of serious outcomes such as heart attack, stroke, and heart failure, while offering better protection for people living with multiple overlapping risk factors.
